IPO, Affiliate Allocation and a Timely Research Note
Harbour Capital is a Hong Kong Type 1 licensed corporation sponsoring the IPO of MediTech, a medical device company. Harbour's affiliate is a joint bookrunner, and a fund managed by Harbour's parent is seeking a cornerstone allocation. Two days before listing, Harbour's research analyst publishes a "Buy" note with a target price 40% above the IPO price. The syndicate desk allocates shares to friends of two MediTech directors, and the stabilisation manager is the same individual who approved the allocation. Harbour's conflicts policy requires disclosure to clients but does not address cornerstone allocations, research independence or stabilisation. The sponsor's due diligence is complete, but the working group has not documented how the conflicts were managed.
1. Identify the conflicts of interest and control failures in this IPO.
Read the worked answer
There are several overlapping conflicts. Harbour is the sponsor and therefore owes an independent duty to the listing applicant and the market, while its affiliate is underwriting the deal and its parent's fund is seeking a cornerstone allocation. Those relationships create incentives to favour the issuer, the affiliate and the parent's fund over independent judgment and other investors. The cornerstone allocation needs a clear assessment of whether the fund is receiving preferential treatment, whether the allocation is on arm's-length terms and whether it is being used to create false demand. The research note published two days before listing raises independence concerns because the analyst may be influenced by the affiliate's underwriting role and the firm's desire to support the deal.
The allocation to friends of directors is a separate governance and possibly anti-bribery issue. Allocation policies must be pre-approved, documented and applied consistently; allocating to connected persons without disclosure or approval is a serious control failure. The same individual acting as stabilisation manager and approving allocations creates a conflict because stabilisation decisions can affect the value of allocations. Harbour's conflicts policy is inadequate because it only requires disclosure and does not address cornerstone allocations, research independence or stabilisation. The absence of documented conflict management is itself a failure; the firm cannot rely on oral assurances that the conflicts were handled.
2. What regulatory obligations and disclosure requirements are engaged?
Read the worked answer
As sponsor, Harbour must comply with the SFC Corporate Finance Adviser Code of Conduct and the HKEX Sponsor Guidelines. It must conduct reasonable due diligence, ensure the listing document is accurate and complete, and manage conflicts of interest. The sponsor should have a conflicts committee or equivalent, and the working group should document how the affiliate's underwriting role, the parent's cornerstone interest and the research coverage were managed. The firm should consider whether the sponsor can act independently given the affiliate and parent relationships, and whether additional controls or disclosure are required.
The research note engages the SFC's research independence requirements and the firm's own policies. Analysts should not be subject to pressure from investment banking colleagues, and research should not be used as marketing for the IPO. The timing and content of the note should be reviewed to determine whether it was independent and whether it complied with restrictions on pre-listing research. The cornerstone allocation requires disclosure in the listing document and an assessment of whether the fund is a connected person or otherwise subject to special disclosure. The allocation to directors' friends may engage the Prevention of Bribery Ordinance if advantages were offered, and it should be reviewed against the firm's allocation policy. Stabilisation must comply with the Securities and Futures Ordinance and HKEX rules, and the stabilisation manager should be independent of the allocation decision.
3. What remediation and governance changes should Harbour implement?
Read the worked answer
Harbour should suspend the individuals involved from further IPO work pending review and preserve all records, including emails, chat messages, allocation sheets and research drafts. It should appoint an independent review team to examine the cornerstone allocation, the research note and the allocations to connected persons. The review should determine whether the fund received preferential terms, whether the research was independent, and whether the stabilisation manager influenced allocations. The firm should consider whether the matter is material enough to notify the SFC and should take legal advice before doing so.
Governance changes should include a strengthened conflicts-of-interest policy with specific controls for cornerstone allocations, affiliate underwriting, research independence and stabilisation. There should be separate reporting lines and physical or information barriers between the sponsor team, syndicate and research. Allocation policies should require pre-approval, documented rationale and disclosure of connected persons. The firm should establish a conflicts committee with senior management oversight, regular training and a register of conflicts. It should also review remuneration and incentives to ensure they do not encourage inappropriate risk-taking. Finally, it should document how conflicts are identified, managed and disclosed, and test the controls before the next IPO mandate.